Abingworth LLP

Holdings History for Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS)

Symbol: CLLS on Nasdaq
Investment type: Equity / Ordinary Shares, nominal value EUR0.05 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2019		-1.5%	$0	0	-100,000	-100%	$4.18	Q1 2019
31 Dec 2018	1.5%	0%	$1,664,000	100,000	0		$16.64	Q4 2018
30 Sep 2018	1.7%	0%	$2,823,000	100,000	0		$28.23	Q3 2018
30 Jun 2018	1.6%	0%	$2,825,000	100,000	0		$28.25	Q2 2018
31 Mar 2018	2%	0%	$3,151,000	100,000	0		$31.51	Q1 2018
31 Dec 2017	2.1%	0%	$2,915,000	100,000	0		$29.15	Q4 2017
30 Sep 2017	2%	0%	$2,842,000	100,000	0		$28.42	Q3 2017
30 Jun 2017	2%	0%	$2,566,000	100,000	0		$25.66	Q2 2017
31 Mar 2017	1.8%	0%	$2,400,000	100,000	0		$24.00	Q1 2017
31 Dec 2016	1.4%	0%	$1,691,000	100,000	0		$16.91	Q4 2016
30 Sep 2016	2.3%	0%	$2,407,000	100,000	0		$24.07	Q3 2016
30 Jun 2016	2.8%	0%	$2,659,000	100,000	0		$26.59	Q2 2016
31 Mar 2016	2.5%	0%	$2,735,000	100,000	0		$27.35	Q1 2016
31 Dec 2015	1.9%	+1.9%	$3,100,000	100,000	+100,000	NEW	$31.00	Q4 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.